References

epilepsia

Epilepsy and paroxysmal conditions

Эпилепсия и пароксизмальные состояния

2077-83332311-4088

IRBIS LLC

10.17749/2077-8333/epi.par.con.2020.032

epilepsia-589

Research Article

SCIENTIFIC SURVEYS

НАУЧНЫЕ ОБЗОРЫ

Vertigo caused by vestibular migraine: current problems of pathogenesis, diagnostics and therapy

Вестибулярная мигрень как причина головокружения: актуальные проблемы патогенеза, диагностики и терапии

https://orcid.org/0000-0003-1570-6607

Беденко

А. С.

Bedenko

A. S.

Беденко Анна Сергеевна - врач-невролог, аспирант, РИНЦ SPIN-код: 1533-6140.

Ул. Трубецкая, д. 8, стр. 2, Москва 119048

Bedenko Anna Sergeevna - neurologist, postgraduate student, RSCI SPIN-code: 1533-6140.

8-2 Trubetskaya Str., Moscow 119048

mailanna91@yandex.ru

Федеральное государственное автономное образовательное учреждение высшего образования Первый Московский государственный медицинский университет имени И.М. Сеченова Министерства здравоохранения Российской Федерации (Сеченовский Университет)РоссияSechenov UniversityRussian Federation

2020

24112020

123177181

2020

Беденко А.С.

Bedenko A.S.

Данная работа распространяется под лицензией Creative Commons Attribution 4.0.

This work is licensed under a Creative Commons Attribution 4.0 License.

https://www.epilepsia.su/jour/article/view/589

Vestibular migraine is one of the most common causes of rotational vertigo, which, however, remains hard to diagnose a nosological entity. There will be discussed pathophysiological mechanisms and current therapeutic approaches along with epidemiology and diagnostic principles for vestibular migraine, which will be of value for hospital and out-patient neurologists as well as general practitioners.

Вестибулярная мигрень - одна из самых частых причин системного головокружения, однако до сих пор эта нозология остается труднодиагностируемой. В статье наряду с эпидемиологией и принципами диагностики рассматриваются патофизиологические механизмы и современные подходы к терапии вестибулярной мигрени.

вестибулярная мигреньголовокружениеголовная больвестибулярные нарушения

vestibular migrainevertigodizzinessheadachevestibular disorders

References1

Табеева Г. Р., Азимова, Ю. Э., Замерград, М В. Современная концепция вестибулярной мигрени (дискуссия). Неврологический журнал. 2012; 17 (2): 45-53.

Tabeeva G.R., Azymova U.A. Zamergard M.V. The modern concept of vestibular migraine (discussion). Neurological journal. 2012; 17 (2): 45-53 (In Russ).

Strupp M., Dieterich M., Brandt T. The Treatment and Natural Course of Peripheral and Central Vertigo. Deutsches Arzteblatt International. 2013; 110 (29-30): 505-516. https://doi.org/10.3238/arztebl.2013.0505.

Kathleen R., Merikangas PhD. Contributions of Epidemiology to Our Understanding of Migraine. Headache. 2013; 53 (2): 230-246. https://doi.org/10.1111/head.12038.

Neuhauser H. K. Epidemiology of vertigo. Curr. Opin. Neurol. 2007; 20: 40-60. https://doi.org/10.1097/WC0.0b013e328013f432.

Neuhauser H. K. Epidemiology of vertigo. Curr. Opin. Neurol. 2007: 20: 40-60. https://doi.org/10.1097/WC0.0b013e328013f432.

Ayzenberg I., Katsarova Z., Mathalikov R., Chernysh M., Osipova V., Tabeeva G., Steiner T.J. The burden of headache in Russia: validation of diagnostic questionnaire in a population based simple. European journal of neurology. 2010; 18: 454-459. https://doi.org/10.1111/j.1468-1331.2010.03177.x.

Bronstein A.M., Lempert T. Dizziness: A Practical Approuch to Diagnosis and Managment. Cambrige University Press; 2007; 83-91.

Bayazit Y., Yilmaz M., Mumbuc S., Kanlikama M. Assessment of migraine-related cochleovestibular symptoms. Revue Laryngol Otol Rhinol. 2001; 122: 85-88.

Гассиева Д.М., Замерград М.В., Табеева Г.Р. Взаимосвязь мигрени и вестибулярных расстройств. Эпилепсия и пароксизмальные состояния. 2019; 11 (1): 88-96. https://doi.org/10.17749/2077-8333.2019.11.1.88-96

Gassieva D.M., Zamergrad M.V., Tabeeva G.R. Association between migraine and vestibular disorders. Epilepsy and paroxysmal conditions. 2019; 11 (1): 88-96. (In Russ.) https:// doi.org/10.17749/2077-8333.2019.11.1.88-96.

Furman J.M., Marcus D.A., Balaban C.D.Vestibular migraine: clinical aspects andpathophysiology. Lancet Neurol. 2013;12 (7): 706-715. https://doi.org/10.1016/S1474-4422(13)70107-8.

Chu C. H., Liu C.J., Lin L.Y., Chen T.J., Wang S.J. Migraine is associatedwith a increased risk for benign paroxysmal positional vertigo: anationwide population-based study. JHeadache Pain. 2015; 16: 62. https://doi.org/10.1186/s10194-015-0547-z.

Chu C. H., Liu C.J., Lin L.Y., Chen T.J., Wang S.J. Migraine is associatedwith a increased risk for benign paroxysmal positional vertigo: anationwide population-based study. J Headache Pain. 2015; 16: 62. https://doi.org/10.1186/s10194-015-0547-z.

Gopen Q., Viirre E., Anderson J: Epidemiologic study to explore linksbetween Meni'ere syndrome and migraine headache. Ear, Noseand Throat Journal. 2009; 88 (11): 1200-1204. https://doi.org/10.1111/j.1526-4610.2009.01557.x.

Radtke A., Neuhauser H., von Brevern M., Hottenrott T., Lempert T.Vestibular migraine validity of clinical diagnostic criteria at long-termfollow-up. J. Vestib. Res. 2010; 20: 207-208. https:// doi.org/10.1177/0333102411405228.

Cha Y. H., Lee H., Santell L. S., BalohR.W. Association of benignrecurrent vertigoand migraine in 208 patients. Cephalalgia. 2009; 29: 550-55. https://doi.org/10.1111/j.1468-2982.2008.01770.x.

The International Classification of Headache Disorders, 3rd edition. Cephalgia. 2018; 38 (1): 1-211. https://doi.org/10.1177/0333102417738202.

Ли А.В., Пархоменко Е.В., Баринов А. Н. Вестибулярная мигрень: диагностика и оптимизация терапии.Журнал неврологии и психиатрии им. С.С. Корсакова. 2017; 117 (8): 59-66. https://doi.org/10.17116/jnevro20171178159-66.

Li A.V., Parchomenko E.V., Barinov A.N. Vestibular migraine: diagnosis and optimization of the therapy. Zhurnalnevrologiiipsi khiatriiimeni S.S. Korsakova (In Russ) https://doi.org/10.17116/jnevro20171178159-66.

Maslovara S., Butkovi Soldo S., Paji-Penavi I., Alkhamis T., Vesligaj T., Soldo A. Vestibular migraine considering new diagnostic criteria. Neurol. Croat. 2014; 63: 1-2.

Gazquez I., Lopez-Escamez J. A. Genetics of recurrent vertigo and vestibular disorders. Curr Genomics. 2011; 12: 443-450. https://doi.org/10.2174/138920211797248600.

Jen J, Kim GW, Baloh RW. Clinical spectrum of episodic ataxia type 2. Neurology. 2004 Jan 13. 62(1 ):17-22. https://doi.org/10.1212/01.wnl.0000101675.61074.50.

Neuhauser H.K., Radtke A. von Brevern M. et al. Migrainous vertigo: Prevalence and impact on quality of life. Neurology. 2006; 67: 1028-1033. https://doi.org/10.1212/01.wnl.0000237539.09942.06.

Bowyer S.M., Aurora K.S., Moran J. E. et al. Magnetoencephalographic fields from patients with spontaneous and induced migraine aura. Ann. Neurol. 2001; 50: 582-587. https://doi.org/10.1002/ana.1293.

Bowyer S.M., Aurora K.S., Moran J. E. et al. Magnetoencephalographic fields from patients with spontaneous and induced migraine aura. Ann. Neurol.2001; 50: 582-587. https://doi.org/10.1002/ana.1293.

Cavestro C., Ferrero M., Mandrino S., Di Tavi M., Rota E. Novelty in Inflammation and Immunomodulation in Migraine. Curr Pharm Des. 2019; 25 (27): 2919-2936. https://doi.org/10.2174/1381612825666190709204107.

Lempert T. Vestibular migraine. Seminars in neurology. 2013; 33 (3): 212-218. https://doi.org/10.1055/s-0033-1354596.

Balaban C.D. Migraine, vertigo and migrainous vertigo: links between vestibular and pain mechanisms. Journal of vestibular research. 2011; 21 (6): 315-321. https://doi.org/10.3233/VES-2011-0428.

Weiller C., May A., Limmroth V. et al. Brain stem activation in spontaneous human migraine attacks. Nat Med.1995; 1: 658-660. https://doi.org/10.1038/nm0795-658.

Formeister E.R., Habib K., Jeffrey Michael S. The Epidemiology of Vestibular Migraine: A Population-based Survey Study. Otology & neurotology: official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology. 2018; 39. https://doi.org/10.1097/MA0.0000000000001900.

Lempert T., von Brevern M. Handbook of Clinical Neurology. 2016; 137: 301-316. https://doi.org/10.1016/B978-0-444-63437-5.00022-4.

Neuhauser H., Radtke A., von Brevern M., Lempert T. Zolmitriptan for treatment of migrainous vertigo: a pilot randomized placebocontrolledtrial. Neurology. 2003; 60 (05): 882-883. https://doi.org/10.1212/01.wnl.0000049476.40047.a3.

Prakash S., Shah N.D. Migrainous vertigo responsive to intravenous methylprednisolone: case reports. Headache. 2009; 49 (08): 1235-1239. https://doi.org/10.1111/j.1526-4610.2009.01474.x.

Bikhazi P., Jackson C., & Ruckenstein M.J. Efficacy of antimigrainous therapy in the treatment of migraine-associated dizziness. The American Journal of Otology. 1997; 18 (3): 350-354.

Perez, Angel J., Dinchen G., Theresa C., George.Topiramate for the Management of Vestibular Migraine. Otolaryngology - Head and Neck Surgery. 2013; 149: 238-238. https://doi.org/10.1177/0194599813496044a291.

Иванова Т.А., Гусева А.Л., Филатова Е.Г. Головокружения при мигрени. Российский медицинский журнал. 2017; 9: 602-606.

IvanovaT.A., GusevaA.L., Philatova E.G. Dizziness with migraine. Russian medical journal. 2017; 9: 602-606 (In Russ).

Stolte B., Holle В., Naegel S. Vestibular migraine. Cephalgia. 2014. https://doi.org/10.1177/0333102414535113.

Lucetti C., Nuti A., Pavese N. et al. Flunarizine in migraine prophylaxis: predictive factors for a positive response. Cephalalgia. 1998; 18: 349-352.

Lucetti C., Nuti A., Pavese N. et al. Flunarizine in migraine prophylaxis: predictive factors for a positive response. Cephalalgia.1998; 18: 349-352.

Bisdorff AR. Treatment of migraine related vertigo with lamotrigine an observational study. Bull Soc Sci Med Grand Duche Luxemb. 2004; 2 (02): 103-108.

Liu F., Ma T., Che X., Wang Q., Yu S. The efficacy of venlafaxine, flunarizine, and valproic acid in the prophylaxis of vestibularmigraine. Front Neurol. 2017; 8: 524. https://doi.org/10.3389/fneur.2017.00524.

Qelebisoy N., Gokgay F., Karahan C. et al. Acetazolamide in vestibular migraine prophylaxis: a retrospective study. Eur Arch Otorhinolaryngol. 2016; 273 (10): 2947-2951. https://doi.org/10.1007/s00405-015-3874-4.

Cacciapuoti F. Migraine homocysteine-related: old and new mechanisms. Neurology and Clinical Neuroscience. 2017; https://doi.org/10.1111/ncn3.12128.

Song, Tae-Jin C., Min S., Jong-Hee A., Hong-Yup L., Sun C., Soo-Jin. Effect of Vitamin D Deficiency on the Frequency of Headaches in Migraine. Journal of Clinical Neurology. 2018; 14 (3): 366. https://doi.org/10.3988/jcn.2018.14.3.366.

Isobe C., Terayama Y. A Remarkable Increase in Total Homocysteine Concentrations in the CSF of Migraine Patients With Aura. Headache. 2010; 50: 1561-1569. https://doi.org/10.1111/j.1526-4610.2010.01713.x.

The authors declare that there are no conflicts of interest present.